Operating Income (Loss) in USD of MUSTANG BIO, INC. from Q1 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Mustang Bio, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2015 to Q3 2025.
  • Mustang Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$624K, a 57.2% increase year-over-year.
  • Mustang Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$2.78M, a 88.4% increase year-over-year.
  • Mustang Bio, Inc. annual Operating Income (Loss) for 2024 was -$16.2M, a 67% increase from 2023.
  • Mustang Bio, Inc. annual Operating Income (Loss) for 2023 was -$49.3M, a 35.3% increase from 2022.
  • Mustang Bio, Inc. annual Operating Income (Loss) for 2022 was -$76.2M, a 14.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

MUSTANG BIO, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$2.78M -$624K +$833K +57.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-07
Q2 2025 -$3.61M -$885K +$7.66M +89.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 -$11.3M -$253K +$4.98M +95.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 -$16.2M -$1.02M +$7.72M +88.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 -$24M -$1.46M +$8.85M +85.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 -$32.8M -$8.54M +$5.35M +38.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 -$38.2M -$5.23M +$11.1M +67.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 -$49.3M -$8.74M +$10.7M +55% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 -$60M -$10.3M +$8.54M +45.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$68.5M -$13.9M +$4.35M +23.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$72.8M -$16.3M +$3.32M +16.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$76.2M -$19.4M +$687K +3.42% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$76.8M -$18.8M -$1.77M -10.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$75.1M -$18.2M -$3.8M -26.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$71.3M -$19.6M -$4.55M -30.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$66.7M -$20.1M +$619K +2.99% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$67.3M -$17.1M -$6.65M -63.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$60.7M -$14.4M -$319K -2.26% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$60.4M -$15.1M -$3.57M -31% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$56.8M -$20.7M -$4.82M -30.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$52M -$10.4M -$431K -4.31% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$51.6M -$14.1M -$3.91M -38.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$47.7M -$11.5M -$1.77M -18.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$45.9M -$15.9M -$4.07M -34.4% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$41.8M -$10M -$2.34M -30.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$39.5M -$10.2M -$4.97M -94.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$34.5M -$9.75M -$3.28M -50.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$31.2M -$11.9M +$3.88M +24.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$35.1M -$7.66M -$572K -8.08% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$34.5M -$5.24M +$425K +7.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$35M -$6.48M -$3.17M -95.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$31.8M -$15.7M -$7.9M -101% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$23.9M -$7.08M -$5.41M -324% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$18.5M -$5.67M -$4.63M -445% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$13.8M -$3.31M -$2.48M -302% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$11.4M -$7.83M -$6.99M -829% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$4.38M -$1.67M -$1.01M -154% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-29
Q2 2016 -$3.36M -$1.04M -$503K -93.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-29
Q1 2016 -$2.86M -$822K +$1.44M +63.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-29
Q4 2015 -$4.3M -$843K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$658K Jul 1, 2015 Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$537K Apr 1, 2015 Jun 30, 2015 10-K 2017-03-31
Q1 2015 -$2.26M Mar 13, 2015 Mar 31, 2015 10-K 2017-03-31

MUSTANG BIO, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$16.2M +$33M +67% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 -$49.3M +$26.9M +35.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 -$76.2M -$9.44M -14.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 -$66.7M -$9.92M -17.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$56.8M -$10.9M -23.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 -$45.9M -$14.7M -47% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
2018 -$31.2M +$562K +1.77% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$31.8M -$20.4M -180% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$11.4M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.